The high cost of making a drug does not justify the high cost at which it is sold
During the Super Bowl a representative of Eli Lilly posted on the company’s corporate blog that the average cost of bringing a new drug to market is $1.3 billion, a price that would buy 371 Super Bowl ads or tickets to fill every seat for every NFL game for six weeks in a row.
(This story appears in the 30 March, 2012 issue of Forbes India. To visit our Archives, click here.)